RT Journal Article
T1 Inhibition of MYC in macrophages: tumor vs inflammation-related diseases
A1 Cano-Ramos, Emilio
A1 Lavín Plaza, Begoña
A1 Pello, Oscar
AB Inhibition of MYC has been postulated as one of the most promising anti-tumoral therapies. However, if some anti-inflammatory cells express MYC, would an anti-tumoral treatment targeting MYC facilitate subsequent inflammation-related disorders?
PB Taylor & Francis
SN 2162-402X
YR 2014
FD 2014
LK https://hdl.handle.net/20.500.14352/96458
UL https://hdl.handle.net/20.500.14352/96458
LA eng
NO Cano-Ramos, Emilio, et al. «Inhibition of MYC in Macrophages: Tumor vs Inflammation-Related Diseases». OncoImmunology, vol. 3, n.o 10, septiembre de 2014, p. e956013. https://doi.org/10.4161/21624011.2014.956013.
DS Docta Complutense
RD 8 abr 2025